Nanjing Julong Science & Technology Co Ltd
Nanjing Julong Science & Technology Co Ltd is a Chinese specialty chemicals company that produces and sells chemical products, primarily for industrial applications.
Business. Nanjing Julong Science & Technology Co Ltd (300644.SZ) is a specialty chemicals company headquartered in Nanjing. The firm operates within the broader chemicals industry, focusing on the production and sale of chemical products. It is primarily listed on the Shenzhen Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Nanjing Julong Science & Technology Co Ltd (300644.SZ) is a specialty chemicals company headquartered in Nanjing. The firm operates within the broader chemicals industry, focusing on the production and sale of chemical products. It is primarily listed on the Shenzhen Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.
Nanjing Julong has a market capitalization of CNY 3.14 billion and a price-to-earnings ratio of 23.72, which is above the industry median for specialty chemicals firms. The company's price-to-book ratio of 2.89 suggests a premium valuation relative to its book value. The liquidity position is mixed, with a negative net cash position after subtracting total debt, and a current ratio of 1.36, indicating moderate short-term liquidity.
Profitability metrics show a return on equity (ROE) of 12.18% and a return on assets (ROA) of 4.91%. These figures are in line with the industry's preferred metrics, though the ROA is slightly below the median for the sector. The company's operating margin is 5.23%, and its net margin is 4.63%, both of which are within the typical range for specialty chemicals firms.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The company's long-term debt of CNY 678.3 million represents 62% of its total equity, indicating a moderate debt load.
Looking ahead, the company is projected to see a 5.2% increase in revenue in the current fiscal year and a 3.8% increase in the following year. These growth rates are in line with the industry's average, but the company's capital expenditures are expected to remain low, with a capex of CNY -20.3 million in the latest period.
The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The negative operating cash flow of CNY -110.7 million is a concern, but the company's free cash flow of CNY 146.9 million provides some buffer. The risk assessment indicates that the company is not currently facing significant dilution pressure, and no recent equity issuance has been reported.
Recent filings and transcripts do not indicate any major strategic shifts or operational disruptions. The company's latest financial report, filed in the fourth quarter, shows stable performance with no material changes in its business model or market position.
- The company is valued at a premium to book, with a P/B ratio of 2.89.
- ROE of 12.18% is in line with industry norms, but ROA of 4.91% is slightly below median.
- Revenue is concentrated in a single segment, increasing exposure to regional and regulatory risks.
- Free cash flow of CNY 146.9 million provides some liquidity buffer despite negative operating cash flow.
- Growth projections are modest, with 5.2% and 3.8% revenue increases expected in the next two fiscal years.
- The company has a low dilution risk and no recent equity issuance reported.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Nanjing Julong Science & Technology Co Ltd Market data — financials · 2026-05-26